Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sympatholysis in CKD
NCT05928936Phase 2Recruiting
- Sponsor
- Emory University
- Start
- Nov 2022
- Primary completion
- Jun 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sodium bicarbonate in chronic kidney disease (CKD), sponsored by Emory University. Started Nov 2022; status: recruiting.
02
Drugs
sodium bicarbonate
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on NCT05928936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05928936.